1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with amyloid beta-peptides in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H; Fujiwara, H; Furukawa, K; Hara, M; Higuchi, M; Ikarashi, Y; Iwasaki, K; Kase, Y; Kudo, Y; Maeda, S; Saido, TC; Sekiguchi, K; Tabuchi, M; Takashima, A; Yaegashi, N; Yamaguchi, T | 1 |
1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and amyloid beta-peptides
| Article | Year |
|---|---|
A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose have potent anti-aggregation effects on Alzheimer's amyloid beta proteins in vitro and in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Avoidance Learning; Behavior, Animal; Cell Line, Transformed; Cell Survival; Chromatography, High Pressure Liquid; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hydrolyzable Tannins; Memory; Mice; Mice, Transgenic; Models, Molecular; Paeonia; Peptide Fragments; Phytotherapy; Plant Extracts; Time Factors | 2009 |